-
How NuVasive is approaching headwinds ahead of merger
NuVasive's CEO Chris Barry remains confident the spine company will meet its planned merger with Globus Medical on schedule, he said in an Aug. 2 earnings call. -
ZimVie sees $23.4M net loss for Q2
ZimVie on Aug. 2 posted $224.9 million in second-quarter sales. -
NuVasive posts Q2 revenue growth ahead of Globus Medical merger
NuVasive on Aug. 2 posted $317.8 million in second quarter sales ahead of its merger with Globus Medical. -
DOCS Health completes enrollment in disc replacement study
DOCS Health of Los Angeles completed enrollment as primary investigators in Centinel Spine's 2-level SMART disc replacement clinical study, the practice said Aug. 1. -
Globus Medical launches Marvel growing rod system for scoliosis
Globus Medical launched its first product designed specifically for early onset scoliosis, the medtech company said July 31. -
Surgalign's businesses auctioned to Xtant Medical, Augmedics
Surgalign's digital health, hardware and biologics businesses have been sold to Xtant Medical and Augmedics through auctions. -
Icotec earns additional FDA nod for Vader system
Icotec's Vader pedicle system navigated instruments earned FDA 510(k) clearance, the medtech company said July 27. -
Michigan payer expands coverage of total disc replacement
Centinel Spine's Prodisc device earned positive coverage by a large commercial payer in Michigan starting Sept. 1. -
The state of AR in spine surgery in 2023
Augmented reality in spine surgery is growing. Last year, several AR spine systems hit the market, and this year surgeons are continuing to adopt the technology. -
Former Medtronic spine exec joins Inspire Medical Systems
Carlton Weatherby, who was vice president and general manager of Medtronic's spine and biologics business, is now Inspire Medical System's chief strategy officer. -
Spine medtech company purchased by BlueRiver Acquisition
Spinal Stabilization Technologies and BlueRiver Acquisition entered into a definitive business combination agreement, according to a July 24 news release. -
Potential FTC lawsuit may challenge Globus Medical-NuVasive deal
The Federal Trade Commission is weighing a potential antitrust lawsuit that could challenge Globus Medical's more than $3 billion proposed acquisition of NuVasive, Seeking Alpha reported July 20. -
Stryker, Zimmer Biomet up revenue projections as elective surgeries rebound
Medical device companies Stryker and Zimmer Biomet are increasing their revenue projections after a surge of elective surgeries. -
7 orthopedic, spine devices recently earning FDA clearance
Here are seven orthopedic and spine devices that have earned FDA clearance that Becker's has reported on since May 30: -
ZimVie stock jumps amid takeover rumors
ZimVie, Zimmer Biomet's spine and dental spinoff comapny, saw a rise in its stock amid reports of takeover interest, Seeking Alpha reported July 17. -
Evolution Spine New Product Launch
Dallas TX - Evolution Spine LLC is proud to announce the first implantation of the E3D-A™ Integrated ALIF cage by Dr. Mark Valente, DISC Spine Institute in Dallas TX. The E3D-A™ Interbody System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Integrated and Static ALIF interbodies. The E3D-A™ Integrated Interbodies are manufactured using 3D-printed Titanium Alloy and feature a double lattice architecture that was designed to encourage bone growth on and through the cage. Dr Valente commented that the E3D-A™ Interbodies “…are a great step forward in the design in interbody cages that provide plenty of room for bone graft and addresses the need for bone ingrowth and ongrowth. I have not personally used another cage on the market that looks like this.” -
6 orthopedic medtech companies earning investor interest
Becker's has reported on six spine and orthopedic medtech companies raising money through investors so far in 2023: -
Spine company releases new instruments for Intracept procedure
Relievant Medsystems released new Intracept Access Instruments for the Intracept procedure, the devicemaker said July 14. -
Spine company raises $35M for SI joint stabilization system
PainTEQ, a spine fusion devicemaker, plans to use $35 million in non-dilutive growth capital to expand the commercialization of its implantable SI joint stabilization system. -
Implanet sees $4.7 million in revenue for 1st half of 2023
Orthopedic medical device manufacturer Implanet has reported an operating revenue of $4.7 million for the first half of 2023, up 4 percent from the first quarter of 2022.
Page 25 of 201